Author

A. P. Drabovich

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:proteomics· 3 Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:protein folding & dynamics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Dimitromanolakis· 1 shared E. P. Diamandis· 1 shared K. Jarvi· 1 shared M. Drabovich· 1 shared M. E. Hyndman· 1 shared P. Saraon· 1 shared T. D. Karakosta· 1 shared W. Tang· 1 shared

Activity by Year

2018-2024 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Dimitromanolakis

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Identification and quantification of human relaxin proteins by immunoaffinity-mass spectrometry

Y. Rais, A. P. Drabovich

This study uses immunoaffinity-selected reaction monitoring to identify and quantify human relaxin proteins, revealing their expression patterns and potential cross-reactivity in biological samples.

bioRxiv · Jan 12, 2024Biochemistry

The proteomic toolbox for identification, quantification, and characterization of polyclonal antibodies

W. Tang, A. P. Drabovich

This paper develops a proteomic toolbox to identify, quantify, and characterize polyclonal antibodies using RSV as a model, revealing key antibody isotypes and gene usage.

bioRxiv · Oct 27, 2023 · PreprintBiochemistry

Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients

A. P. Drabovich, P. Saraon, M. Drabovich, T. D. Karakosta, A. Dimitromanolakis, M. E. Hyndman, K. Jarvi, E. P. Diamandis

The paper identifies TGM4 as a potential biomarker in seminal plasma for prostate cancer detection and prognosis, outperforming PSA and age in some cases.

bioRxiv · May 7, 2018Cancer Biology